Unprotected Left Main Stenting in the Real World Two-Year Outcomes of the French Left Main Taxus Registry

Article

关键词: CORONARY-ARTERY-DISEASE;    DRUG-ELUTING STENT;    LONG-TERM OUTCOMES;    BIFURCATION LESIONS;    MULTICENTER REGISTRY;    IMPLANTATION;    PREDICTORS;    REVASCULARIZATION;    THROMBOSIS;    CLASSIFICATION;   

DOI  :  10.1161/CIRCULATIONAHA.108.804930

来源: SCIE

【 摘 要 】

Background-Cardiac surgery is the reference treatment for patients with left main (LM) disease, although percutaneous coronary intervention with drug-eluting stents is emerging as a possible alternative. The objective of this registry was to evaluate the 2-year outcome of elective percutaneous coronary intervention for unprotected LM disease with paclitaxel-eluting stents. Methods and Results-A total of 291 patients were prospectively included from 4 centers. Acute myocardial infarction and cardiogenic shock were the only exclusion criteria. Patients were 69 +/- 11 years old, 29% were diabetic, and 25% had 3-vessel disease. For distal LM lesions (78%), the provisional side-branch T-stenting approach was used in 92% of cases and final kissing balloon inflation in 97%. Angiographic success was obtained in 99.7% of cases. At 2-year follow-up, the total cardiac death rate was 5.4% (1 EuroSCORE point was associated with a 15% [ 95% confidence interval 2.9% to 28.2%, P = 0.013] higher risk of cardiac death), target-lesion revascularization was 8.7%, and incidence of Q-wave or non-Q-wave myocardial infarction was 0.9% and 3.1%, respectively. The combined end point occurred in 15.8% of cases and stroke in 0.7%. The incidence of definite and probable LM stent thrombosis was 0.7%, whereas the incidence of any stent thrombosis was 3.8%, with a higher risk in patients with side-branch stenting in the presence of LM bifurcation lesions (hazard ratio 9.6, 95% confidence interval 1.2 to 77.7, P = 0.035). Conclusions-Unprotected LM stenting with paclitaxel- eluting stents, with a strategy of provisional side-branch T-stenting for distal lesions, provides excellent acute angiographic results and good mid-term clinical outcomes, with a 15.8% rate of major adverse cardiac events at 2-year follow-up. (Circulation. 2009; 119: 2349-2356.)

【 授权许可】

Free